Rapid HIV Testing and Counseling in High Risk Women in Shelters

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Brown University
The Miriam Hospital
Indiana University
Information provided by (Responsible Party):
Dawn Johnson, The University of Akron
ClinicalTrials.gov Identifier:
NCT01866046
First received: May 28, 2013
Last updated: May 30, 2013
Last verified: May 2013
  Purpose

This is a developmental study evaluating a new rapid HIV testing and risk prevention intervention for residents of battered women's shelters who endorse risky sexual behaviors.


Condition Intervention Phase
HIV Risk
Behavioral: RESPECT-IPV
Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Rapid HIV Testing and Counseling in High Risk Women in Shelters

Resource links provided by NLM:


Further study details as provided by The University of Akron:

Primary Outcome Measures:
  • number of unprotected sexual occasions [ Time Frame: up to 3 months post shelter ] [ Designated as safety issue: No ]
    Calendar assessment of number of unprotected sexual occasions


Estimated Enrollment: 100
Study Start Date: January 2013
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: RESPECT-IPV
Rapid HIV testing and risk prevention intervention for victims of intimate partner violence
Behavioral: RESPECT-IPV
rapid HIV testing intervention and behavioral counseling session where identify risks and develop a risk reduction plan

  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • intimate partner violence and at least one unprotected sexual occasion 3 months prior to entering shelter

Exclusion Criteria:

  • HIV positive
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01866046

Locations
United States, Ohio
University of Akron
Akron, Ohio, United States, 44325
Sponsors and Collaborators
The University of Akron
Brown University
The Miriam Hospital
Indiana University
  More Information

No publications provided

Responsible Party: Dawn Johnson, Associate Professor, The University of Akron
ClinicalTrials.gov Identifier: NCT01866046     History of Changes
Other Study ID Numbers: R21NR13628-02
Study First Received: May 28, 2013
Last Updated: May 30, 2013
Health Authority: United States: NIH

Keywords provided by The University of Akron:
battered women
HIV risk
STI risk

Additional relevant MeSH terms:
HIV Antibodies
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on October 23, 2014